AbbVie

ABBV · United States

AbbVie traded $1.3B on 23 Oct 2026, 0.9× its 20-session average. Sector: Diversified Pharma & Biotech.

504 trading days of history, to 2026-10-23 · all values converted to USD

Last close
$285.64
23 Oct
1-day change
+0.16%
vs previous close
Market cap
$504.8B
as of 23 Oct
Turnover
0.26%
of market cap traded
Dollar volume
$1.3B
as of 23 Oct
vs prior 20 sessions
0.9×
as of 23 Oct
Share of market volume
0.34%
as of 23 Oct
Volatility
27.4%
annualised

Infinity volume insights

since 14 April 2025

Every session our rules flagged for this company since 14 April 2025: 9. Those marked “In the feed” were published in the daily feed at the time; the rest are computed with the rules in use now. The feed shows a few a day across every market, so most never appear there. We began tracking this company on 28 September 2026; findings before then are marked “Before we tracked it”: it traded that way, and we were not yet watching.

  1. 2026-06-26Before we tracked it

    AbbVie had its heaviest session in the 421 sessions on record

    Above the previous high of $5.7B. $13.3B against a 20-day average of $1.4B, on a rising price (+4.2%). The +4.2% move is 2.3 standard deviations from its usual daily change. Dollar volume 9.4× normal; turnover 3.0% of market cap (8.4× its usual turnover).

The latest is shown; the other 8 open with the full page.

This is a preview

A free account opens five company pages a day in full: every insight, the year's chart, the volume by week and month, fundamentals and peers. Members open every company, with full charting.

See what moves AbbVie's share price For members · Sign in

Prices and volume via the daily pipeline, converted to USD.

Report data issue

← Back to United States